Danaher Corporation $DHR Shares Acquired by Temasek Holdings Private Ltd

Temasek Holdings Private Ltd boosted its position in shares of Danaher Corporation (NYSE:DHR) by 7.3% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 306,776 shares of the conglomerate’s stock after buying an additional 20,920 shares during the period. Temasek Holdings Private Ltd’s holdings in Danaher were worth $58,165,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter valued at about $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Morgan Stanley reduced their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Royal Bank Of Canada started coverage on Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective for the company. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $231.64.

More Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher posted Q2 adjusted EPS of $1.94, above the $1.84 consensus, and revenue of about $6.26 billion to $6.3 billion, also ahead of estimates. Danaher Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year adjusted EPS guidance, showing confidence in profitability despite the softer sales backdrop. Danaher Corp (DHR) Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Life Sciences was a bright spot, with stronger sales growth, but bioprocessing revenue came in weaker than expected and was cited as a drag on sentiment. Reuters: Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise
• Negative Sentiment: Investors reacted negatively to the reduced core revenue growth outlook and cautious near-term guidance, which outweighed the earnings beat and led to the stock decline. Danaher stock slips despite Q2 earnings beat, raised guidance
• Negative Sentiment: Analysts also highlighted “surprisingly soft” bioprocessing sales, reinforcing concerns that growth may slow more than expected. Danaher Plummets After One Segment Comes In ‘Surprisingly Soft’

Danaher Stock Performance

Shares of DHR opened at $179.01 on Wednesday. The company has a 50-day moving average of $184.22 and a two-hundred day moving average of $197.69. The stock has a market cap of $126.70 billion, a price-to-earnings ratio of 34.62, a PEG ratio of 2.48 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.10. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.11 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 earnings per share. On average, equities research analysts expect that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.